CONNECTEVE Co., Ltd. is a growing MedTech startup offering AI-powered diagnostic tools used in hospital settings. based in Seoul, Korea. Founded in 2021, their flagship product, Connevo, uses advanced AI algorithms to analyze arthritis progression from X-ray images, and is already sold in Asia, Europe, and the Middle East. The analysis provides valuable clinical insights to physicians and patients directly at the point of care. Since this solution is designed for hospital use, it operates entirely within secure, on-premises environments (including offline), ensuring robust protection for sensitive patient data and compliance with medical privacy regulations.
Since deploying Thales Sentinel, CONNECTEVE has begun to generate revenue by offering their proprietary diagnostic software securely and efficiently. The company now enjoys the ability to launch new products with Sentinel’s capabilities such as:
A range of flexible licensing models, including custom licensing duration terms
Subscriptions, starting with free trials, and
Software and IP protection
This scalability has proven essential to their growth and differentiation within the highly competitive medical imaging sector.